3. Mechanism comparison
BPC-157 mechanism (primary axes): VEGFR2 activation → angiogenesis FAK-paxillin pathway → fibroblast migration Nitric oxide system modulation EGR1 pathway engagement Protection against corticosteroid-induced healing impairment TB-500 mechanism (primary axes):
This comparison does not assign a generated winner or score.
- BPC-157 mechanism (primary axes):
- VEGFR2 activation → angiogenesis
- FAK-paxillin pathway → fibroblast migration
- Nitric oxide system modulation
- EGR1 pathway engagement
- Protection against corticosteroid-induced healing impairment
- TB-500 mechanism (primary axes):
- G-actin binding and sequestration (canonical thymosin beta-4 function)
- Cell migration regulation via actin cytoskeleton dynamics
- Angiogenesis via endothelial cell migration (not VEGFR2-mediated primarily)
- Anti-inflammatory signalling
- Stem/progenitor cell recruitment in cardiac repair models
- The mechanistic takeaway: both engage angiogenesis and cell migration, but through distinct molecular targets. BPC-157 acts predominantly via growth factor receptor signalling (VEGFR2) and fibroblast-specific pathways; TB-500 acts via cytoskeletal regulation and broader cell-migration machinery.